Cerebral vasospasm after aneurysmal subarachnoid hemorrhage: an overview of pharmacologic management.
about
Nicardipine in the treatment of aneurysmal subarachnoid haemorrhage: a meta-analysis of published data.Novel Actions of Nonsteroidal Anti-Inflammatory Drugs on Vascular Ion Channels: Accounting for Cardiovascular Side Effects and Identifying New Therapeutic Applications.Cerebral Vasospasm in Critically III Patients with Aneurysmal Subarachnoid Hemorrhage: Does the Evidence Support the Ever-Growing List of Potential Pharmacotherapy Interventions?MEK1/2 inhibitor U0126 but not endothelin receptor antagonist clazosentan reduces upregulation of cerebrovascular contractile receptors and delayed cerebral ischemia, and improves outcome after subarachnoid hemorrhage in rats.peroxisome proliferator-activated receptor alpha activation-mediated regulation of endothelin-1 production via nitric oxide and protein kinase C signaling pathways in piglet cerebral microvascular endothelial cell culture.Statin treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage.Hemostatic therapy for the treatment of intracranial hemorrhage.Role of intraarterial therapy for cerebral vasospasm secondary to aneurysmal subarachnoid hemorrhage.Inflammation, cerebral vasospasm, and evolving theories of delayed cerebral ischemia.Incidence of and factors associated with manipulation of nimodipine dosage in patients with aneurysmal subarachnoid hemorrhage.Normal basilar artery structure and biaxial mechanical behaviour.Endothelin-1 expression and alterations of cerebral microcirculation after experimental subarachnoid hemorrhage.Accuracy of nimodipine gel extraction.
P2860
Q30575416-08A78209-B0F2-4DFF-84C7-53628B3C426CQ34043009-EA031957-D506-4196-9AD4-6DE707BDB6B9Q34612924-AF94A4AF-CEAD-41D0-AF3F-6C6D0EC2497CQ35591265-4305EBA2-9D7D-4A1E-A7EF-29E0B945309BQ35853780-9D818542-697F-4A66-A392-7592F8E0C8E4Q36994718-74EFFBC3-2597-405C-973C-86F34073DA79Q37117872-EFB52B24-CAFF-4604-BDE6-9673B9739A3CQ37718233-D1E17A72-F5D3-48D0-A3BF-52F8F77388CDQ38140874-FFA0E60B-2810-4CD9-B5F4-9615228114AAQ41988321-DA8E81E4-7D20-43F6-8F88-2FFA6E4F6E01Q43424122-43C7C1D4-BBCA-4D76-95E8-BA4B89FE1A89Q48496513-EED1C138-321B-4203-9D6E-8B0EA3B5134EQ48603858-2AE3D5E6-8D06-4562-80A2-E13BF533AE0F
P2860
Cerebral vasospasm after aneurysmal subarachnoid hemorrhage: an overview of pharmacologic management.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Cerebral vasospasm after aneur ...... w of pharmacologic management.
@ast
Cerebral vasospasm after aneur ...... w of pharmacologic management.
@en
type
label
Cerebral vasospasm after aneur ...... w of pharmacologic management.
@ast
Cerebral vasospasm after aneur ...... w of pharmacologic management.
@en
prefLabel
Cerebral vasospasm after aneur ...... w of pharmacologic management.
@ast
Cerebral vasospasm after aneur ...... w of pharmacologic management.
@en
P2860
P356
P1433
P1476
Cerebral vasospasm after aneur ...... w of pharmacologic management.
@en
P2093
Denise H Rhoney
Xi Liu-Deryke
P2860
P304
P356
10.1592/PHCO.26.2.182
P407
P577
2006-02-01T00:00:00Z